BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ISIS-EIF4ERx: Phase II started

Isis began an open-label, U.S. Phase II trial in about 100 patients to evaluate prednisone and Taxotere docetaxel with and without IV ISIS-EIF4ERx...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >